scholarly journals Intravenous Immunoglobulin Therapy in Pediatric Narcolepsy: A Nonrandomized, Open-Label, Controlled, Longitudinal Observational Study

2017 ◽  
Vol 13 (03) ◽  
pp. 441-453 ◽  
Author(s):  
Michel Lecendreux ◽  
Johanna Berthier ◽  
Jennifer Corny ◽  
Olivier Bourdon ◽  
Claire Dossier ◽  
...  
Keyword(s):  
Observational Study ◽  
Intravenous Immunoglobulin ◽  
Immunoglobulin Therapy ◽  
Open Label ◽  
Intravenous Immunoglobulin Therapy ◽  
Longitudinal Observational Study

scholarly journals Intravenous immunoglobulin therapy in kidney transplant recipients with de novo DSA: Results of an observational study

PLoS ONE ◽  
2017 ◽  
Vol 12 (6) ◽  
pp. e0178572 ◽  
Author(s):  
Marie Matignon ◽  
Caroline Pilon ◽  
Morgane Commereuc ◽  
Cynthia Grondin ◽  
Claire Leibler ◽  
...  
Keyword(s):  
Observational Study ◽  
Intravenous Immunoglobulin ◽  
Kidney Transplant ◽  
De Novo ◽  
Immunoglobulin Therapy ◽  
Transplant Recipients ◽  
Kidney Transplant Recipients ◽  
Intravenous Immunoglobulin Therapy

scholarly journals Intravenous Immunoglobulin Therapy for Streptococcal Toxic Shock Syndrome—A Comparative Observational Study

1999 ◽  
Vol 28 (4) ◽  
pp. 800-807 ◽  
Author(s):  
Rupert Kaul ◽  
Allison McGeer ◽  
Anna Norrby‐Teglund ◽  
Malak Kotb ◽  
Benjamin Schwartz ◽  
...  
Keyword(s):  
Observational Study ◽  
Intravenous Immunoglobulin ◽  
Toxic Shock Syndrome ◽  
Immunoglobulin Therapy ◽  
Streptococcal Toxic Shock Syndrome ◽  
Toxic Shock ◽  
Intravenous Immunoglobulin Therapy

scholarly journals Transient Hypogammaglobulinemia and Severe Atopic Dermatitis: Open-label Treatment with Immunoglobulin in a Case Series

2016 ◽  
Vol 7 (2) ◽  
pp. ar.2016.7.0164 ◽  
Author(s):  
Moira E. Breslin ◽  
Joanna H. Lin ◽  
Robert Roberts ◽  
Kellie J. Lim ◽  
E. Richard Stiehm
Keyword(s):  
Atopic Dermatitis ◽  
Los Angeles ◽  
Intravenous Immunoglobulin ◽  
Conventional Therapy ◽  
Case Series ◽  
Retrospective Chart Review ◽  
Immunoglobulin Therapy ◽  
Severe Atopic Dermatitis ◽  
Open Label ◽  
Intravenous Immunoglobulin Therapy

Background We reported on six infants between 5 and 11 months old, with transient hypogammaglobulinemia of infancy and severe refractory atopic dermatitis, who were treated with open-label immunoglobulin (Ig) after conventional therapy failed. All six infants had an IgG level of <225 mg/dL, elevated eosinophil and IgE levels, and no urine or stool protein losses, but they did exhibit hypoalbuminemia. Objective To evaluate the utility of open-label immunoglobulin in infants with severe atopic dermatitis for whom conventional therapy failed. We reviewed the clinical utility of intravenous immunoglobulin in the treatment of severe atopic dermatitis, the most recent research in the field, and suggested mechanisms for its benefit. Methods The six infants were identified from a retrospective chart review at the University of California Los Angeles Allergy and Immunology outpatient pediatric clinic. Results All six patients were treated with 400 mg/kg/month of intravenous immunoglobulin and had normalization of their IgG and albumin levels, and all but one had clinically improved atopic dermatitis. Conclusion Infants with severe atopic dermatitis who did not respond to conventional therapy avoidance may benefit from intravenous immunoglobulin therapy.

Sign in / Sign up

Export Citation Format

Share Document